EUVIMEDEUVIMED entdecken
Crossref

α-Bisabolol and royal jelly differentially mitigate thioacetamide-induced hepatic fibrosis in rats associated with the inhibition of TGF-β1/FAK/α-SMA signaling

Sara T Elazab, Rania Essam Ali Gamal Eldin

Food and Chemical Toxicology · 2024

DOI: 10.1016/j.fct.2024.115069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Sara T Elazab und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt. Electronic address: sara.taha@ymail.com. Hauptthemen laut MEDLINE: Thioacetamide, Transforming Growth Factor beta1, Liver Cirrhosis, Actins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic fibrosis is a global health burden that accounts for high mortality. No definitive therapy to suppress the fibrosis so far. Thus, looking for an effective remedy to address the unmet medical need is crucial. We aimed to scrutinize the efficacy of royal jelly (RJ) and/or α-Bisabolol (BISA) in the regression of fibrosis provoked by thioacetamide (TAA), focusing on their action on redox status, NF-κBp65, apoptosis, and TGF-β1/FAK/α-SMA pathway. TAA was injected intraperitoneally twice weekly to trigger hepatic fibrosis. Rats were gavaged with RJ (100 mg/kg) and/or BISA (50 mg/kg) daily for 8 weeks. The findings elucidated that RJ and/or BISA alleviated TAA-provoked fibrosis mirrored by the improvement of hepatotoxicity serum indices, abolishing oxidative stress, and repair the morphological alterations. Additionally, RJ and BISA suppressed the hepatic inflammation induced by TAA through downregulating NF-κBp65 expression, reducing TNF-α and IL-6 concentrations, and elevating IL-10 level. Their anti-fibrotic effect was emphasized from the decline in FAK, Smad3, COL-III, hydroxyproline levels, and TGF-β1, α-SMA immunoexpression. BISA displayed better ameliorative action than RJ. Conclusively, RJ and/or BISA possess a hepatoprotective activity against TAA-mediated fibrosis by enhancing antioxidant defense, inhibiting NF-κBp65, and modulating TGF-β1/FAK/α-SMA signaling. RJ and BISA might be prospective candidates to combat hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThioacetamideTransforming Growth Factor beta1Liver CirrhosisActinsSignal TransductionFatty AcidsFocal Adhesion Kinase 1Monocyclic SesquiterpenesAnimalsRatsMaleOxidative StressRats, WistarLiverRoyal Jelly

Stichwörter der Autor:innen

Liver fibrosisOxidative stressRoyal jellyTGF-β1/FAK/α-SMA pathwayThioacetamideα-Bisabolol

Substanzen

ThioacetamideTransforming Growth Factor beta1ActinsFatty AcidsFocal Adhesion Kinase 1Monocyclic SesquiterpenesRoyal JellyPtk2 protein, ratActa2 protein, ratTgfb1 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt. Electronic address: sara.taha@ymail.com.
  • Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.

Förderung

  • Mansoura University

Zitieren

APA

Elazab, S. T., & Eldin, R. E. A. G. (2024). α-Bisabolol and royal jelly differentially mitigate thioacetamide-induced hepatic fibrosis in rats associated with the inhibition of TGF-β1/FAK/α-SMA signaling. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.115069

Vancouver

Elazab ST, Eldin REAG. α-Bisabolol and royal jelly differentially mitigate thioacetamide-induced hepatic fibrosis in rats associated with the inhibition of TGF-β1/FAK/α-SMA signaling. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.115069

BibTeX
@article{Elazab2024,
  author = {Elazab, Sara T and Eldin, Rania Essam Ali Gamal},
  title = {α-Bisabolol and royal jelly differentially mitigate thioacetamide-induced hepatic fibrosis in rats associated with the inhibition of TGF-β1/FAK/α-SMA signaling},
  journal = {Food and Chemical Toxicology},
  year = {2024},
  doi = {10.1016/j.fct.2024.115069}
}
Kostenlos starten →